EMC
30
-26
PSX
24
2
STT
48
4
VNO
46
6
DIS
70
2
ZION
49
9
HPQ
55
3
THC
52
9
PNC
48
6
LNC
28
3
IRM
33
5
SWK
53
4
PHM
44
4
GME
61
2
R
55
-2
O
26
16
ED
39
8
CINF
24
-8
WBA
41
3
CHD
34
7
EMC
30
-26
PSX
24
2
STT
48
4
VNO
46
6
DIS
70
2
ZION
49
9
HPQ
55
3
THC
52
9
PNC
48
6
LNC
28
3
IRM
33
5
SWK
53
4
PHM
44
4
GME
61
2
R
55
-2
O
26
16
ED
39
8
CINF
24
-8
WBA
41
3
CHD
34
7
Financhill
Back

Paramount Group 10K Form

Sell
32

PGRE
Paramount Group

Last Price:
$4.81
Seasonality Move:
-6.13%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive PGRE News And Ratings

See the #1 stock for the next 7 days that we like better than PGRE

PGRE Financial Statistics

Sales & Book Value

Annual Sales: $742.8M
Cash Flow: $39.7M
Price / Cash Flow: 3.75
Annual Sales: $14.59
Price / Book: 0.33

Profitability

EPS (TTM): -0.98000
Net Income (TTM): $-213.2M
Gross Margin: $448.8M
Return on Equity: -5.2%
Return on Assets: -2.66%

Paramount Group Earnings Forecast

Key Paramount Group Financial Ratios

  • The Gross Profit Margin over the past 13 years for PGRE is 60.42%.
  • The Selling, General & Administrative Expenses for PGRE have been equal to 8.35% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is -56.51% of Operating Income.
  • The Net Earning history of PGRE is -34.97% of Total Revenues.
  • Per Share Earnings over the last 13 years have been positive in 5 years.

Paramount Group Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Office REITs
Sector: Real Estate
Current Symbol: PGRE
CUSIP: 69924R
Website: pgre.com

Debt

Debt-to-Equity Ratio: 1.16
Current Ratio: 7.55
Quick Ratio: 6.04

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

PGRE Technical Analysis vs Fundamental Analysis

Sell
32
Paramount Group (PGRE) is a Sell

Is Paramount Group a Buy or a Sell?

  • Paramount Group stock is rated a Sell
    The current Paramount Group [PGRE] share price is $4.81. The Score for PGRE is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.